Navigation Links
Vasogen Announces Second Quarter 2008 Results
Date:7/9/2008

MISSISSAUGA, ON, July 9 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) today reported the results of operations for the three and six months ended May 31, 2008. All dollar amounts referenced herein are in Canadian dollars unless otherwise noted.

At May 31, 2008, our cash and cash equivalents totaled $12.4 million, compared with $19.9 million at February 29, 2008.

The net loss for the second quarter of 2008 was $7.4 million, or $0.33 per common share, compared with a net loss of $9.7 million, or $0.54 per common share for the same period in 2007. We incurred a net loss for the six months ended May 31, 2008 of $12.7 million, or $0.57 per common share, compared with a net loss of $17.4 million, or $1.02 per common share for the same period in 2007. A key driver of this decrease was a reduction in expenses resulting from the repayment of the senior convertible notes in April 2007, lower restructuring costs, reduced stock compensation expense, lower infrastructure and other support costs driven by lower employee numbers in 2008, and a decrease in the foreign exchange loss that was incurred in the prior periods.

Corporate Update

- On April 14, 2008, we announced the implementation of a strategic

restructuring plan to significantly reduce our cash burn rate and

focus our efforts on opportunities that the Board and Management

believe are most likely to provide shareholder value. As a result

of this restructuring, our work force was reduced by approximately

85% during the quarter. As a result, we are no longer maintaining

the necessary quality processes or personnel to support European

commercialization o
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Vasogen Provides Corporate Update
2. Vasogen to Webcast Presentation at the Rodman & Renshaw 5th Annual Global Healthcare Conference
3. Vasogen Receives NASDAQ Notification Related to Minimum Bid Price
4. Vasogen Announces Implementation of Strategic Restructuring Plan
5. Vasogen Announces First Quarter 2008 Results
6. Vasogen to Webcast its Annual Meeting
7. Vasogen Provides Update on ACCLAIM II Program
8. Vasogen to Present at the BIO CEO & Investor Conference and Participate on the Non-Cancer Immunotherapy Panel
9. Vasogens Research Published in European Journal of Neuroscience
10. The Lancet Publishes Vasogens ACCLAIM Results
11. Vasogen Announces 2007 Year-End Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... June 1, 2015 Shire plc ... will be participating in the Jefferies 2015 Global Healthcare ... on Tuesday, June 2, 2015. Jeff Poulton , ... answer session at 10:00 a.m. ET (3:00 p.m. BST). ... on the Presentations and Webcasts section of Shire,s Investor ...
(Date:6/1/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/tdw3ss/2015_strategies ) has ... in the UK Flow Cytometry Market" report ... a comprehensive analysis of the UK flow cytometry ... the French flow cytometry practice, as well as ... with significant market impact during the next five ...
(Date:6/1/2015)... 1, 2015 Hutchison China ... AstraZeneca AB (publ) ("AstraZeneca"), Hutchison MediPharma Limited,s ("HMP") ... Phase Ib clinical trial of HMP,s c-Met inhibitor ... in non-small cell lung cancer ("NSCLC"). ... growth factor receptor (EGFR). Preliminary data on the ...
(Date:5/31/2015)... 31, 2015 The most heavily attended ... Clinical Oncology (ASCO) Annual Meeting – “The Plenary Session ... prominently featured presentations by immunotherapy experts and members of ... Patrick Allison, PhD, chairman of the Department of Immunology ... and SITC committee member, received the Science of Oncology ...
Breaking Biology Technology:Strategies in the UK Flow Cytometry Market 2015 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 2Savolitinib (AZD6094) Preliminary Phase Ib Clinical Data in Lung Cancer Presented at the 2015 ASCO Annual Meeting 3SITC Reports on Immunotherapy Insights and Data Featured at ASCO Plenary Session 2
... Inc. (Nasdaq: TNGN ), a leader in regenerative ... Executive Officer of Tengion, will present at the upcoming 13th ... 2011, at 2:00 p.m. EST.  Dr. Nichtberger will also participate ... Open?" the following day on Tuesday, February 15, 2011, at ...
... University of California, Berkeley, have found a way to grow ... lead to a new class of faster, more efficient microprocessors, ... chips. They describe their work in a ... issue of the journal Nature Photonics . ...
... Feb. 4, 2011 AVAX Technologies, Inc. (Pink Sheets: ... announced that it filed a Form 10 with the ... this Form 10, AVAX will once again become a ... have its common stock trade on the Over-the-Counter Bulletin ...
Cached Biology Technology:Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann 'Hot Topics in Therapeutics' Roundtable Conference 2Engineers grow nanolasers on silicon, pave way for on-chip photonics 2Engineers grow nanolasers on silicon, pave way for on-chip photonics 3AVAX Technologies, Inc. Files Form 10 With SEC 2
(Date:5/21/2015)... BOSTON , May 21, 2015 ... scientific potential of music for health, today announced a ... (BerkleeICE) . The partnership will center on collaboration on ...  As a first step in the collaboration, The Sync ... course on "Music as Medicine" in the 2015-2016 academic ...
(Date:5/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... 3D-ID LLC, a company engaged in biometric identification is ... technology portion of the recently awarded TIES (Technical Information ... the Army. 3D-ID LLC has a suite ... enforcement and security agencies. Gino Pereira ...
(Date:5/19/2015)...  Technology is rapidly advancing, outpacing enterprises, ability to ... Passwords and their management are soon to be rendered ... such as those developed by the FIDO Alliance™. With ... for BYOD, COPE, IoT, and mobile payments, the interconnected ... In response to the call for seamless, ...
Breaking Biology News(10 mins):The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3
... hunters and not the last ice age are the likely ... North American great mammals such as mammoths, mastodons and saber-toothed ... the first arrival of humans or the warm-up of the ... was responsible for the demise of prehistoric sloths has puzzled ...
... Wildfires in Alaska and Canada in 2004 emitted about ... the continental United States during the same time period, ... Atmospheric Research (NCAR). The fires also increased atmospheric concentrations ... , The NCAR study, which indicates the extent to ...
... Hitchcock's "The Birds" made many of us uneasy at the ... around the world are beginning to cast an equally uneasy ... of avian influenza in Southeast Asia and, last week, in ... and North American flyways for migratory birds and scientists say ...
Cached Biology News:Study shows big game hunters, not climate change, killed off sloths 2Study shows big game hunters, not climate change, killed off sloths 3NCAR analysis shows widespread pollution from 2004 wildfires 2On a wing and a prayer - Alaska researchers seek clues to bird flu 2On a wing and a prayer - Alaska researchers seek clues to bird flu 3
... High Sensitivity Laboratory Osmometer for both 0.2 and 2.0 mL samples for freezing ... record keeping. Bar code reading capability with optional scanner. RS-232 port. ... ... ...
The Light Diagnostics Calicivirus Genotype 1&2 Typing OligoDetect assay is applicable for the qualitative detection of calicivirus RNA generated by an in-house validated in vitro nucleic acid amplifi...
X-Gal...
Recombinant Rat CINC-2 alpha, CF...
Biology Products: